ArticleScientific reports2025
Molecular and serological evidence of spotted fever group rickettsiae and Borrelia co-infection in Ixodes ricinus and humans in north-eastern Poland.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tick-borne spotted fever group (SFG) rickettsioses are considered emerging vector-borne infectious diseases with potentially severe consequences for public health, particularly in the temperate regions of Europe. The aim of the study was to determine the prevalence and the diversity of Rickettsia spp. in questing Ixodes ricinus ticks in north-eastern Poland, evaluate the serological evidence of exposure to SFG rickettsiae among adult residents of this region, as well as to determine the level of SFG rickettsiae co-infection with Borrelia spirochaetes in ticks and humans. In a total of 4090 ticks, the presence of Rickettsia spp. was detected by PCR and confirmed by sequencing. IgG antibodies against SFG Rickettsia and Borrelia were detected using ELISA. Rickettsial DNA was revealed in 11.3% of females, 11.8% of males and nymphs of 6.5% (MIR, minimum infection rate). Based on DNA sequencing, R. helvetica and R. monacensis were identified. IgG antibodies against SFG rickettsiae were confirmed in 38.7% of adult residents of north-eastern Poland. The co-infection rate of SFG rickettsiae with Borrelia spirochaetes in questing adult I. ricinus ticks was low (2.6%), compared to the co-infection rate (16.1%) observed based on the presence of immunological responses in the study group of residents from northeastern Poland. These findings provide important evidence filling the gap between the environmental detection of SFG rickettsiae in vector populations and the limited number of diagnosed clinical cases in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.